Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: retrospective follow up study

BMC Research Notes
Nebiyu MekonnenMelaku Kindie Yenit

Abstract

The aim of this study was to estimate the incidence of lost to follow up from anti-retroviral therapy (ART) care and identify the associated factors among human immunodeficiency virus (HIV) infected patients after first-line ART initiation at University of Gondar comprehensive specialized hospital, Northwest Ethiopia between January 2012 and January 2018. The overall incidence rate of lost to follow up was 12.26 per 100 person years (95% CI (10.61-14.18)). Being underweight (< 18.5 kg/m2) (AHR, 1.52, 95% CI 1.01-2.28), jobless (AHR, 2.22, 95% CI 1.2-4.11), substance abuser (AHR, 1.84 95% CI 1.19-2.86), having sub-optimal adherence (fair/poor) (AHR 6.33, 95% CI (3.90-10.26)), not receiving isoniazid prophylaxis (AHR 2.47, 95% CI (1.36-4.48)), ambulatory functional status (AHR 1.94, 95% CI (1.23-3.06)), having opportunistic infections (AHR, 1.74 95% CI 1.11-2.72), having CD4 count 201-349 cells/µL (AHR 0.58, 95% CI (0.38-0.88)) were found to be significant predictors of lost to follow up from ART service.

References

Nov 14, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Geetanjali ChanderRichard D Moore
Jun 9, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ingrid V BassettKenneth A Freedberg
Jul 14, 2010·Tropical Medicine & International Health : TM & IH·Matthew P Fox, Sydney Rosen
Sep 25, 2010·Bulletin of the World Health Organization·Vincent Ochieng-OokoPaula Braitstein
Oct 16, 2014·North American Journal of Medical Sciences·Tezera Moshago BerhetoSalahuddin Mohammed
May 6, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew P Fox, Sydney Rosen
Jul 5, 2015·BMC Health Services Research·Mazvita Naome MberiRobert Summers
Jul 15, 2015·Journal of the International AIDS Society·Gabriela CarriquiryBryan Earl Shepherd
May 14, 2016·HIV/AIDS : Research and Palliative Care·Abebe MegersoZelalem Habtamu
Jul 19, 2016·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Dec 22, 2017·Indian Journal of Dermatology·Anupam DasNilay Kanti Das

❮ Previous
Next ❯

Citations

Nov 10, 2021·Expert Review of Anti-infective Therapy·Hossam AbdelazizWahid Doss

❮ Previous
Next ❯

Software Mentioned

Epi Info

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.